Earnings History Data for Bicycle Therapeutics (BCYC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Bicycle Therapeutics
Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31-10-2024 | PM | BCYC | Bicycle Therapeutics | 1,162 | -0.74 | -0.78 | 0.00 | Bicycle Therapeutics GAAP EPS of -$0.74 beats by $0.02, revenue of $2.68M misses by $4.33M [10/31/2024 7:52 AM] |
23.49 | -0.54 (-2.25%) |
23.33 | -0.70 (-2.91%) |
12.54 - 28.67 | 435,752 | 430,000 | 204 | ||
| 06-08-2024 | PM | BCYC | Bicycle Therapeutics | 1,082 | -0.77 | -1.10 | 0.00 | Bicycle Therapeutics GAAP EPS of -$0.77 beats by $0.35, revenue of $9.36M beats by $3.08M [8/6/2024 7:26 AM] |
24.41 | 1.70 (7.49%) |
0.0 | 0.0 (0.00%) |
12.54 - 27.24 | 439,326 | 270,000 | 0 | ||
| 20-02-2024 | PM | BCYC | Bicycle Therapeutics | 676.00 | -1.16 | -1.23 | 0.00 | Bicycle Therapeutics GAAP EPS of -$1.16 beats by $0.15, revenue of $5.33M misses by $1.55M [2/20/2024 9:22 AM] |
22.67 | 0.17 (0.76%) |
22.52 | 0.02 (0.09%) |
12.54 - 28.91 | 330,060 | 390,000 | 137 | ||
| 28-02-2023 | PM | BCYC | Bicycle Therapeutics | 478.00 | -1.01 | -1.06 | 0.00 | Bicycle Therapeutics GAAP EPS of -$1.01 beats by $0.05, revenue of $3.19M misses by $0.56M [2/28/2023 7:43 AM] |
22.78 | -0.42 (-1.81%) |
0.0 | 0.0 (0.00%) |
12.08 - 50.47 | 362,171 | 560,000 | 0 | ||
| 01-03-2022 | PM | BCYC | Bicycle Therapeutics | 1,402 | -0.63 | -0.60 | 0.00 | Bicycle Therapeutics GAAP EPS of -$0.63 beats by $0.01, revenue of $3.77M misses by $1.11M [3/1/2022 7:48 AM] |
46.90 | -0.60 (-1.26%) |
47.50 | 0.0 (0.00%) |
20.67 - 62.08 | 236,292 | 130,000 | 820 | ||
| 05-08-2021 | PM | BCYC | Bicycle Therapeutics plc | 744.48 | -0.74 | -0.72 | -0.67 | Bicycle Therapeutics EPS misses by $0.02, misses on revenue [8/5/2021 7:52 AM] |
29.55 | 0.14 (0.48%) |
0.0 | 0.0 (0.00%) |
15.34 - 36.99 | 84,538 | 180,000 | 0 | ||
| 06-05-2021 | PM | BCYC | Bicycle Therapeutics plc | 753.95 | -0.73 | -0.66 | -0.63 | Bicycle Therapeutics EPS misses by $0.05, beats on revenue [5/6/2021 7:29 AM] |
31.77 | 0.61 (1.96%) |
0.0 | 0.0 (0.00%) |
13.32 - 33.20 | 120,791 | 80,000 | 0 | ||
| 11-03-2021 | PM | BCYC | Bicycle Therapeutics Plc Sponsored Adr | 542.00 | -0.83 | -0.50 | 0.00 | Bicycle Therapeutics EPS misses by $0.32, beats on revenue [3/11/2021 7:25 AM] |
27.01 | -0.34 (-1.24%) |
0.0 | 0.0 (0.00%) |
10.26 - 33.00 | 85,461 | 129,728 | 0 | ||
|
||||||||||||||||||
| 05-11-2020 | PM | BCYC | Bicycle Therapeutics plc | 362.93 | -0.52 | -0.66 | -0.53 | Bicycle Therapeutics EPS beats by $0.12, beats on revenue [11/5/2020 7:24 AM] |
19.00 | 0.23 (1.23%) |
18.75 | -0.02 (-0.11%) |
7.50 - 21.59 | 41,001 | 29,082 | 100 | ||
|
|
||||||||||||||||||